Buradasınız

Anasayfa » Content

Bartter Sendromu Tip І: Bir Olgu Sunumu

Bartter Syndrome Type І: A Case Report

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2012
DOI: 
DOI 10.5262/tndt.2012.1003.21

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Salt-losing tubulopathies with secondary hyperaldosteronism are genetic disorders that involve the thick ascending limb of Henle’s loop and the distal convoluted tubule. Bartter syndrome type І is a saltlosing renal tubular disorder and mimics the laboratory features of chronic treatment with loop diuretics such as hyponatremia, hypokalemia, hypercalciuria. In this report, a patient with Bartter syndrome type І is presented and the clinical and laboratory fi ndings and treatment are reviewed.
Bookmark/Search this post with
Abstract (Original Language): 
Sekonder hiperaldosteronizmin eşlik ettiği tuz kaybettiren nefropatiler, Henle kulpunun çıkan kalın kolu ve distal kıvrımlı tubulü ilgilendiren kalıtımsal bozukluklara bağlı gelişen bir grup sendromdur. Bartter sendromu tip І, bu grupta yer alır ve hiponatremi, hipopotasemi, hiperkalsiüri gibi ‘loop’ diüretikleri ile tedaviyi taklit eden laboratuvar özelliklere sahiptir. Bu yazıda, Bartter sendromu tip І tanısı alan bir hasta sunulmakta, sendromun klinik - laboratuvar bulguları ve tedavisi gözden geçirilmektedir.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_21_pp_307-309.pdf
  • 3
307-309
  • Turkish

REFERENCES

References: 

1. Devuyst O: Tubular Disorders of Electrolye Regulation. In: Avner
ED, Harmon WE, Nıaudet P, Yoshikawa N, Pediatric Nephrology,
(6th ed). Berlin Heidelberg: Springer-Verlag, 2009; 929-935
2. Seyberth HW, Schlingmann KP: Bartter- and Gitelman-like
syndromes: Salt-losing tubulopathies with loop or DCT defects.
Pediatr Nephrol 2011; 26: 1789-180
3. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nüsing RM,
Seyberth HW, Kömhoff M: Role of cyclooxygenase-2 in
hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Kidney Int 2002; 62: 253-260
4. Haycock GB: The infl uence of sodium on growth in infancy. Pediatr
Nephrol 1993; 7: 871-875
5. Gil-Peña H, Mejia N, Alvarez-Garcia O, Loredo V, Santos F:
Longitudinal growth in chronic hypokalemic disorders. Pediatr
Nephrol 2010; 25: 733-737
6. Seidel C, Reinalter S, Seyberth HW, Schärer K: Pre-pubertal growth
in the hyperprostaglandin E syndrome. Pediatr Nephrol 1995; 9:
723-728
7. Vaisbich MH, Fujimura MD, Koch VH: Bartter syndrome: Benefi ts
and side effects of long-term treatment. Pediatr Nephrol 2004; 19:
858-863
8. Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F,
Tedeschi S, Bianchetti MG; Italian Collaborative Group for Bartter
Syndrome: Long-term follow-up of patients with Bartter syndrome
type I and II. Nephrol Dial Transplant 2010; 25: 2976-2981
9. Kleta R, Bockenhauer D: Bartter syndromes and other salt-losing
tubulopathies. Nephron Physiol 2006; 104: 73-80

Thank you for copying data from http://www.arastirmax.com